Peptides by condition · Muscles, bones, joints and skin
Peptides studied for skin wounds and ulcers
Checked against our study pages and the FDA labelsPublished by PepVault
Our library holds 10 study pages on skin wounds and ulcers: 5 in people (all meta-analyses or randomized trials), and 5 in animals. They studied 6 compounds, with this many study pages each: LL-37 2, HGH 1, TB-500 2, GHK-Cu 3, BPC-157 1 and Thymosin Beta-4 1.
What the research on skin wounds and ulcers looks like
Wounds that are slow to close are a common problem with diabetes, poor circulation and old age; diabetic foot ulcers and venous leg ulcers are the main types. The peptides studied for wound healing were mostly put on the skin as a gel or cream, and the work spans small trials in people and wound models in mice and rats.
Wound studies in people measure how much of the wound has closed, how many wounds closed fully, and the healthy new tissue that fills the base, called granulation. Animal studies time how fast a cut or burn closes and look at collagen under a microscope.
Ulcers in people have causes, such as poor blood flow, that a wound cut in a healthy animal does not have. Look for a placebo or standard-care comparison, since many ulcers close with good wound care alone.

The 10 studies, by compound
Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.
LL-37
2 in peopleFor skin wounds and ulcers, 2 of our study pages are filed under LL-37: 2 randomized trials in people. The largest in people enrolled 148 people and was published in 2021. They were published from 2021 to 2023, in Wound Repair Regen and Arch Dermatol Res.
LL-37 has no FDA-approved product: Drugs@FDA lists no application for it.
- Randomized trial in people · 148 people · 2021LL-37: no healing gain over placebo for venous leg ulcers overall
- Randomized trial in people · 2023LL-37 cream: bigger granulation gains in diabetic foot ulcers
HGH
1 in peopleFor skin wounds and ulcers, 1 of our study pages is filed under HGH: 1 meta-analysis in people. It pooled 701 people and was published in 2014, in Cochrane Database Syst Rev.
FDA-approved for other uses, not for skin wounds and ulcers: Humatrope (injection) for growth failure in children who make too little growth hormone and several other causes of short stature, and growth hormone deficiency in adults.
- Meta-analysis in people · 701 people · 2014HGH: adult burn wounds healed 9.07 days faster in a meta-analysis
TB-500
1 in people · 1 in animalsFor skin wounds and ulcers, 2 of our study pages are filed under TB-500: 1 randomized trial in people, and 1 animal study (mice). The largest in people enrolled 73 people and was published in 2010. They were published from 2003 to 2010, in Ann N Y Acad Sci and Wound Repair Regen.
TB-500 has no FDA-approved product: Drugs@FDA lists no application for it or for thymosin beta-4.
- Randomized trial in people · 73 people · 2010TB-500 on venous ulcers: safety comparable to placebo in Phase 2
- Animal study in mice · 2003Thymosin beta-4 sped skin wound healing in diabetic and aged mice
GHK-Cu
1 in people · 2 in animalsFor skin wounds and ulcers, 3 of our study pages are filed under GHK-Cu: 1 randomized trial in people, and 2 animal studies (mice and rats). Its study in people does not give their size on our pages. They were published from 1993 to 2017, in Wound Repair Regen and J Clin Invest.
GHK-Cu has no FDA-approved drug: Drugs@FDA lists no application for it.
- Randomized trial in people · 1994GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%
- Animal study in mice · 2017GHK-Cu liposomes sped scald wound healing in mice
- Animal study in rats · 1993GHK-Cu increased collagen and tissue buildup in rat wound chambers
BPC-157
1 in animalsFor skin wounds and ulcers, 1 of our study pages is filed under BPC-157: 1 animal study (rats). It was published in 2015, in Drug Des Devel Ther.
BPC-157 has no FDA-approved product: Drugs@FDA lists no application for it.
- Animal study in rats · 2015BPC-157 sped alkali burn wound closure in rats
Thymosin Beta-4
1 in animalsFor skin wounds and ulcers, 1 of our study pages is filed under Thymosin Beta-4: 1 animal study (rats). It was published in 1999, in J Invest Dermatol.
Thymosin beta-4 has no FDA-approved product: Drugs@FDA lists no application for it.
- Animal study in rats · 1999Thymosin Beta-4 sped full thickness skin wound healing in rats
Side by side
For the 6 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).
| Compound | In people | Animals or cells | Largest in people | FDA |
|---|---|---|---|---|
| LL-37 | 2 | 0 | 148 | Not approved |
| HGH | 1 | 0 | 701 | Approved for other uses |
| TB-500 | 1 | 1 | 73 | Not approved |
| GHK-Cu | 1 | 2 | — | Not approved |
| BPC-157 | 0 | 1 | — | Not approved |
| Thymosin Beta-4 | 0 | 1 | — | Not approved |
- In people
- 2
- Animals or cells
- 0
- Largest in people
- 148
- FDA
- Not approved
- In people
- 1
- Animals or cells
- 0
- Largest in people
- 701
- FDA
- Approved for other uses
- In people
- 1
- Animals or cells
- 1
- Largest in people
- 73
- FDA
- Not approved
- In people
- 1
- Animals or cells
- 2
- Largest in people
- —
- FDA
- Not approved
- In people
- 0
- Animals or cells
- 1
- Largest in people
- —
- FDA
- Not approved
- In people
- 0
- Animals or cells
- 1
- Largest in people
- —
- FDA
- Not approved
What the studies did not show
Each study page names its own limits. These are the questions still open, in the study pages’ words.
- LL-37: no healing gain over placebo for venous leg ulcers overallThe trial missed its main goal in the full group, and the large-wound benefit comes from a post hoc subgroup analysis the trial was not designed or sized to test. The researchers say a new trial sized for patients with large ulcers is needed.
- HGH: adult burn wounds healed 9.07 days faster in a meta-analysisEach pooled result rests on only a few small trials that carried a risk of bias, and none of the included trials tracked wound infection. The authors say larger, higher quality trials are needed to confirm the results.
- TB-500 on venous ulcers: safety comparable to placebo in Phase 2This was a small, early-stage trial, and its signs of faster healing were preliminary, not a firm result. It tested the peptide applied to the skin of venous ulcers only, so it says nothing about other uses or other ways of giving it.
- GHK-Cu liposomes sped scald wound healing in miceThis is work in mice and lab-grown cells, not a human result. It tested GHK-Cu inside liposomes, so the findings apply to that form.
- BPC-157 sped alkali burn wound closure in ratsAll results come from rats and lab-grown cells, not people. The study tested a single type of burn model.
- Thymosin Beta-4 sped full thickness skin wound healing in ratsThis was work in rats and in cells, so it is not a result in people. It followed wounds for only 7 days.
This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.
Questions
Which peptides have been studied for skin wounds and ulcers?
Our 10 study pages on skin wounds and ulcers are filed under 6 compounds, with this many each: LL-37 2, HGH 1, TB-500 2, GHK-Cu 3, BPC-157 1 and Thymosin Beta-4 1. GHK-Cu has the most.
Have any been tested in people with skin wounds and ulcers?
Yes: 5 of the 10 were in people, all of them meta-analyses or randomized trials (LL-37, HGH, TB-500 and GHK-Cu). The largest pooled 701 people: “HGH: adult burn wounds healed 9.07 days faster in a meta-analysis” (2014).
Is any peptide FDA-approved for skin wounds and ulcers?
Not by the labels our status pages read: of the 6 compounds here with an FDA record, none has a use tied to skin wounds and ulcers. HGH is FDA-approved for other uses.
How large were the studies in people on skin wounds and ulcers?
Of the 5 in people, 3 give their size on our pages: 2 had 100 to 999 and 1 had fewer than 100. The largest, a meta-analysis from 2014, pooled 701.
What did the animal and cell studies on skin wounds and ulcers use?
5 animal studies (mice and rats), filed under GHK-Cu, BPC-157, TB-500 and Thymosin Beta-4. A result in animals or cells shows what to test next, not what happens in a person.
What is the newest study on skin wounds and ulcers here?
Of our study pages on skin wounds and ulcers, the newest is “LL-37 cream: bigger granulation gains in diabetic foot ulcers”, a randomized trial in people published in 2023.
How this page was built
A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.
Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.